Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cyclacel Pharmaceuticals Inc. buy Roth Mkm

Start price
€0.22
19.12.23 / 50%
Target price
€19.12
19.12.24
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 19.12.24. The prediction end date can be changed by Roth_Mkm at any time.
Performance without dividends (%)
Name 1w 1m
Cyclacel Pharmaceuticals Inc. - -
iShares Core DAX® -0.922% -1.078%
iShares Nasdaq 100 0.371% -0.556%
iShares Nikkei 225® 2.224% -2.825%
iShares S&P 500 -0.026% -0.788%

Comments by Roth_Mkm for this prediction

In the thread Cyclacel Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 19.121
Change
Ends at 19.12.24

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) had its price target raised by analysts at Roth Mkm from $16.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for CYCC provided by MarketBeat

Stopped prediction by Roth_Mkm for Cyclacel Pharmaceuticals Inc.

buy
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.22
03.05.24
€10.21
03.05.25
-
15.12.23